Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients aged between 18 to 55 years of age of either gender. 2. Patients with clinically diagnosed cases of symptomatic reticular/erosive oral lichen planus. 3. Patients with OLP who have not received any treatment for the lesions in the past 4 weeks will be included. 4. Patient voluntarily willing to be a part of the study after signing the informed consent
Exclusion criteria
Exclusion criteria: 1. Pregnant or breast feeding women. 2. Patients on any other drugs, or steroids either topically or systemically or with chronic debilitating diseases who are on long term medications. 3. Patients with any other associated oral disorder such as leukoplakia, OSMF.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This study will be carried to assess the effectiveness of N. sativa in comparison with triamcinolone acetonide, in reducing pain and burning sensation, as well as their effects on improvement of oral lesions.Timepoint: This study will be carried to assess the effectiveness of N. sativa in comparison with triamcinolone acetonide, in reducing pain and burning sensation, as well as their effects on improvement of oral lesions. | — |
Secondary
| Measure | Time frame |
|---|---|
| This study will be carried to assess the effectiveness of N. sativa in comparison with triamcinolone acetonide, in reducing pain and burning sensation, as well as their effects on improvement of oral lesions.Timepoint: | — |
Countries
India
Contacts
Bharati Vidyapeeth Dental College and Hospital Deemed to be University Pune